Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/132764
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Birth outcomes for Australian mother-infant pairs who received an influenza vaccine during pregnancy, 2012-2014: the FluMum study
Author: McHugh, L.
Andrews, R.M.
Lambert, S.B.
Viney, K.A.
Wood, N.
Perrett, K.P.
Marshall, H.S.
Richmond, P.
O'Grady, K.A.F.
Citation: Vaccine, 2017; 35(10):1403-1409
Publisher: Elsevier
Issue Date: 2017
ISSN: 0264-410X
1873-2518
Statement of
Responsibility: 
Lisa McHugh, Ross M.Andrews, Stephen B.Lambert, Kerri A.Viney, Nicholas Woodd, Kirsten P.Perrett ... et al.
Abstract: INTRODUCTION: In Australia, influenza vaccination is recommended for all women who will be pregnant during the influenza season. Vaccine safety and effectiveness are key concerns and influencers of uptake for both vaccine providers and families. We assessed the safety of receiving an influenza vaccination during any trimester of pregnancy with respect to preterm births and infant birthweight. METHODS: We conducted a nested retrospective cohort study of 'FluMum' participants (2012-2014). Our primary exposure of interest was influenza vaccination during pregnancy. The primary outcomes of interest were infant birthweight and weeks' gestation at birth for live singleton infants. Analyses included comparisons of these birth outcomes by vaccination status and trimester of pregnancy an influenza vaccine was given. We calculated means, proportions, and relative risks and performed multivariable logistic regression for potential confounding factors. RESULTS: In the 7126 mother-infant pairs enrolled in this study, mean maternal age at infant birth was 31.7years. Influenza vaccine uptake in pregnancy was 34%. Most mothers with a known date of vaccination received a vaccine in the second trimester (51%). Those mothers with a co-morbidity or risk factor were 13% more likely to have influenza vaccine during pregnancy compared to other mothers (RR 1.13, 95% CI 1.04-1.24, p=0.007). Mean weeks' gestation at birth was 38.7 for the vaccinated and 38.8 for the unvaccinated group (p=0.051). Infants in the vaccinated group weighed 15g less in birthweight compared to the unvaccinated infants (95% CI -12.8 to 42.2, p=0.29). CONCLUSION: Results arising from this large Australian cohort study are reassuring with respect to two critical safety outcomes; preterm births and low infant birthweights. Studies examining a broader range of birth outcomes following influenza vaccination during pregnancy are required, particularly now that maternal vaccination in pregnancy has expanded to include pertussis as well as influenza.
Keywords: Birth outcomes
Immunisation
Influenza
Maternal vaccination
Pregnancy
Safety
Rights: ©2017 Elsevier Ltd. All rights reserved.
DOI: 10.1016/j.vaccine.2017.01.075
Grant ID: http://purl.org/au-research/grants/nhmrc/1020035
http://purl.org/au-research/grants/nhmrc/1036231
http://purl.org/au-research/grants/nhmrc/1063629
http://purl.org/au-research/grants/nhmrc/1054394
http://purl.org/au-research/grants/nhmrc/1084951
http://purl.org/au-research/grants/nhmrc/1045157
Published version: http://dx.doi.org/10.1016/j.vaccine.2017.01.075
Appears in Collections:Obstetrics and Gynaecology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.